Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced ...

Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing ...

Congenital heart defects (CHDs) represent the most prevalent class of birth anomalies, affecting approximately 1 in 100 live births worldwide. A substantial proportion of these defects arise in the ...

The majority of rare diseases have a genetic cause. The underlying genetic alteration can be found more and more easily, for example by means of exome sequencing (ES), leading to a molecular genetic ...

As predictive medicine advances, legal scholars warn that decades-old federal guidelines could set up a potential clash between your genes and your job.

Chronic kidney disease (CKD) is a public health challenge that affects more than 800 million people worldwide. 1 CKD can be caused by a variety of disease processes. Many causes are difficult to ...

Screens 595 carefully selected genes associated with childhood-onset conditions where early intervention may improve outcomesDesigned for maternity hospitals, obstetrics practices, newborn care ...

Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with ...

Whether genes are able to compromise between their competing interests can have consequences for development. pressureUA/iStock via Getty Images Plus As a species, humans like to think that we are ...

The medical literature overwhelmingly characterizes the Druze as what researchers call a “genetic isolate,” meaning that ...